Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Wilber Sabiiti

Biographic Data

ID6164155
NAMEWilber Sabiiti
GIVEN NAMESWilber
FAMILY NAMESabiiti
SIGNATURESABIITI W
AFFILIATIONSUniversity of St Andrews
ORCID0000-0002-4742-2791
VERIFIEDYes
TOTAL WORKS15
TOTAL CITATIONS0
AUTHOR COUNT7
EDITOR COUNT8
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2025
H-INDEX0
  • The role of Rwanda Field Epidemiology and Laboratory Training Program graduates and residents in response to the first Marburg Virus Disease outbreak in Rwanda

    Open Access•Edouard Ruseesa, Aphrodis Hagabimana et al.•ARTICLE•PLOS Global Public Health•2025

    Rwanda Field epidemiology and laboratory training programs (RFELTP) build capacity to improve disease surveillance, respond to public health emergencies, and inform evidence-based decision-making to mitigate the impact of epidemics and other public health events. On September 27, 2024, Rwanda declared its first Marburg virus disease (MVD) outbreak. MVD disease is a severe haemorrhagic fever with a fatality rate ranging from 24% to 90%. We describ…

  • Screening and targeted sequencing of stool for microbiologic confirmation and drug resistance determination in paucibacillary tuberculosis

    Open Access•Tara E Ness, Mangaliso Ziyane et al.•ARTICLE•PLOS Global Public Health•2025

    In 2023, an estimated 10.8 million people developed tuberculosis, and 1.25 million people died from this disease, including 161,000 deaths in people with HIV (PWH) in whom tuberculosis remains the leading cause of death. Detecting Mycobacterium tuberculosis drug resistance remains a challenge among patients with paucibacillary tuberculosis; since there is such low bacterial load in their sputum it’s unable to be detected via microscopy, there is …

  • A laboratory-focussed desk review of health systems in Uganda, Kenya, and the UK to respond to current and future pandemics

    Open Access•Winters Muttamba, Bernadette O’hare et al.•ARTICLE•Journal of Global Health•2025

    Background: Laboratory systems play a crucial role in managing diseases effectively, and the COVID-19 pandemic serves as a prime example. The pandemic underscored the need to make laboratory health systems more resilient and robust to respond to future pandemics. Methods: We conducted a desk review guided by the six World Health Organization health system building blocks (health service delivery, health financing, medical products, vaccines, and …

  • Unpacking ‘irrational’ behaviours

    Open Access•Olga Loza, Mike Kesby et al.•ARTICLE•Global Public Health•2025

    Stewardship of antibiotic medicines will likely play a key role in curtailing the rise of antimicrobial resistance (AMR) globally. In East Africa, drug sellers are a critical group for interventions because they often dispense without prescription and violate regulations designed to facilitate antibiotic stewardship. Currently, measures to tackle regulatory avoidance are often rooted in individuated cognitive-behavioural approaches that label sel…

  • Treatment seeking behaviours, antibiotic use and relationships to multi-drug resistance

    Open Access•Keina Sado, Katherine Keenan et al.•ARTICLE•PLOS Global Public Health•2024

    Antibacterial resistance (ABR) is a major public health threat. An important accelerating factor is treatment-seeking behaviour, including inappropriate antibiotic (AB) use. In many low- and middle-income countries (LMICs) this includes taking ABs with and without prescription sourced from various providers, including health facilities and community drug sellers. However, investigations of complex treatment-seeking, AB use and drug resistance in …

  • Wastewater metagenomics in Africa

    Open Access•Stephen Kanyerezi, Fatma Z Guerfali et al.•ARTICLE•PLOS Global Public Health•2024

    The advent of metagenomics has dramatically expanded our understanding of microbial communities, particularly through the study of wastewater, which serves as a rich source of microbial data. In Africa, wastewater metagenomics presents unparalleled opportunities for public health monitoring, antimicrobial resistance (AMR) tracking, and the discovery of new microbial species and functions. Utilizing high-throughput sequencing (HTS) technologies, t…

  • Cross border population movements across three East African states

    Open Access•Patrick King, Mercy Wendy Wanyana et al.•ARTICLE•PLOS Global Public Health•2024

    The frequent population movement across the five East African Countries poses risk of disease spread in the region. A clear understanding of population movement patterns is critical for informing cross-border disease control interventions. We assessed population mobility patterns across the borders of the East African states of Kenya, Uganda, and Rwanda. In November 2022, we conducted Focus Group Discussions (FGDs), Key Informant Interviews (KIIs…

  • Clinical symptoms and faecal shedding of Sars-CoV-2 RNA among hospitalized Covid-19 patients

    Open Access•Rebecca Folasade Bamidele, Adeola Fowotade et al.•ARTICLE•PLOS Global Public Health•2024

    SARS-CoV-2 shedding in human stool has been suggested as a probable route for faeco-oral transmission of the virus due to the availing evidence on the infectivity and pathogenicity of similar highly infectious respiratory viruses. Determining association of SARS-CoV-2 shedding in stools and presenting clinical status might be useful for prediction of the viral transmission spectrum and disease outcome. This study involved a descriptive cross-sect…

  • Treatment seeking and antibiotic use for urinary tract infection symptoms in the time of Covid-19 in Tanzania and Uganda

    Open Access•Emmanuel Olamijuwon, Katherine Keenan et al.•ARTICLE•Journal of Global Health•2024

    Background: There is still little empirical evidence on how the outbreak of coronavirus disease 2019 (COVID-19) and associated regulations may have disrupted care-seeking for non-COVID-19 conditions or affected antibiotic behaviours in low- and middle-income countries (LMICs). We aimed to investigate the differences in treatment-seeking behaviours and antibiotic use for urinary tract infection (UTI)-like symptoms before and during the pandemic at…

  • Adverse Drug Reactions Resulting From the Use of Chiral Medicines Amoxicillin, Amoxicillin-Clavulanic Acid, and Ceftriaxone

    Open Access•Kissa W Mwamwitwa, Elias M Bukundi et al.•ARTICLE•INQUIRY The Journal of Health…•2024

    The use of chiral medicines (possessing center(s) of asymmetric carbon) may cause adverse drug reactions (ADRs). The safety assurance of these medicines is critical. We aimed to evaluate registered and commonly used anti-infective chiral medicines circulating in the Tanzanian market to establish their safety profile to protect public health. A mixed prospective-retrospective cohort study was conducted to assess the safety profile of amoxicillin, …

  • Ebola incidence and mortality before and during a lockdown

    Open Access•Jonathan Izudi, Allan Komakech et al.•ARTICLE•PLOS Global Public Health•2023

    On September 20, 2022, an Ebola Disease (EBOD) outbreak was declared in Mubende district, Central Uganda. Following a rapid surge in the number of cases and mortality, the Government of Uganda imposed a lockdown in the two most affected districts, Mubende and Kassanda. We describe the trends in EBOD incidence and mortality nationally and in the two districts before and during the lockdown and the lessons learned during the epidemic response. We r…

  • Knowledge, perceptions and practices on antimicrobial resistance in humans and animals in Wakiso district, Uganda

    Open Access•David Musoke, Grace Biyinzika Lubega et al.•ARTICLE•PLOS Global Public Health•2023

    Despite increasing evidence on antimicrobial resistance (AMR), there is limited literature on antimicrobial access and use in humans and animals in community settings globally. This study assessed knowledge and perceptions of AMR, as well as practices relating to the use of antimicrobials in humans and animals in Wakiso district, Uganda. This was a cross-sectional study among 418 participants that employed quantitative data collection methods. A …

  • Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts–A cross-sectional study

    Open Access•Sivaprakasam T Selvavinayagam, Bijulal Aswathy et al.•ARTICLE•PLOS Global Public Health•2023

    Early detection of latent tuberculosis infection (LTBI) is critical to TB elimination in the current WHO vision of End Tuberculosis Strategy . The study investigates whether detecting plasma cytokines could aid in diagnosing LTBI across household contacts (HHCs) positive for IGRA, HHCs negative for IGRA, and healthy controls. The plasma cytokines were measured using a commercial Bio-Plex Pro Human Cytokine 17-plex assay. Increased plasma CXCL8 an…

  • Global inequity of Covid-19 diagnostics

    Shanti Narayanasamy, Brenda Okware et al.•ARTICLE•Journal of Epidemiology and…•2022•References: 14

    Diagnostics for COVID-19 have advanced at an unprecedented pace over the last two years. Testing is a critical pillar of pandemic control, and is required for epidemiological tracking, treatment, and surveillance. Despite high quality SARS-CoV-2 viral diagnostic capability, there are vast global inequities in access. The Virology, Immunology, and Diagnostics Working Group(WG) of the COVID-19 Clinical Research Coalition (CRC) brings together exper…

  • Unlocking the health system barriers to maximise the uptake and utilisation of molecular diagnostics in low-income and middle-income country setting

    Open Access•Nyanda Elias Ntinginya, Davis Kuchaka et al.•ARTICLE•BMJ Global Health•2021

    BACKGROUND: Early access to diagnosis is crucial for effective management of any disease including tuberculosis (TB). We investigated the barriers and opportunities to maximise uptake and utilisation of molecular diagnostics in routine healthcare settings. METHODS: /rifampicin (MTB/RIF) and Line Probe Assay (LPA) as a benchmark, we evaluated the barriers and how they could be unlocked to maximise uptake and utilisation of molecular diagnostics. R…

No prominent works on this page.

  • Unlocking the health system barriers to maximise the uptake and utilisation of molecular diagnostics in low-income and middle-income country setting

    Open Access•Nyanda Elias Ntinginya, Davis Kuchaka et al.•ARTICLE•BMJ Global Health•2021

    BACKGROUND: Early access to diagnosis is crucial for effective management of any disease including tuberculosis (TB). We investigated the barriers and opportunities to maximise uptake and utilisation of molecular diagnostics in routine healthcare settings. METHODS: /rifampicin (MTB/RIF) and Line Probe Assay (LPA) as a benchmark, we evaluated the barriers and how they could be unlocked to maximise uptake and utilisation of molecular diagnostics. R…

  • Global inequity of Covid-19 diagnostics

    Shanti Narayanasamy, Brenda Okware et al.•ARTICLE•Journal of Epidemiology and…•2022•References: 14

    Diagnostics for COVID-19 have advanced at an unprecedented pace over the last two years. Testing is a critical pillar of pandemic control, and is required for epidemiological tracking, treatment, and surveillance. Despite high quality SARS-CoV-2 viral diagnostic capability, there are vast global inequities in access. The Virology, Immunology, and Diagnostics Working Group(WG) of the COVID-19 Clinical Research Coalition (CRC) brings together exper…

  • Ebola incidence and mortality before and during a lockdown

    Open Access•Jonathan Izudi, Allan Komakech et al.•ARTICLE•PLOS Global Public Health•2023

    On September 20, 2022, an Ebola Disease (EBOD) outbreak was declared in Mubende district, Central Uganda. Following a rapid surge in the number of cases and mortality, the Government of Uganda imposed a lockdown in the two most affected districts, Mubende and Kassanda. We describe the trends in EBOD incidence and mortality nationally and in the two districts before and during the lockdown and the lessons learned during the epidemic response. We r…

  • Knowledge, perceptions and practices on antimicrobial resistance in humans and animals in Wakiso district, Uganda

    Open Access•David Musoke, Grace Biyinzika Lubega et al.•ARTICLE•PLOS Global Public Health•2023

    Despite increasing evidence on antimicrobial resistance (AMR), there is limited literature on antimicrobial access and use in humans and animals in community settings globally. This study assessed knowledge and perceptions of AMR, as well as practices relating to the use of antimicrobials in humans and animals in Wakiso district, Uganda. This was a cross-sectional study among 418 participants that employed quantitative data collection methods. A …

  • Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts–A cross-sectional study

    Open Access•Sivaprakasam T Selvavinayagam, Bijulal Aswathy et al.•ARTICLE•PLOS Global Public Health•2023

    Early detection of latent tuberculosis infection (LTBI) is critical to TB elimination in the current WHO vision of End Tuberculosis Strategy . The study investigates whether detecting plasma cytokines could aid in diagnosing LTBI across household contacts (HHCs) positive for IGRA, HHCs negative for IGRA, and healthy controls. The plasma cytokines were measured using a commercial Bio-Plex Pro Human Cytokine 17-plex assay. Increased plasma CXCL8 an…

  • Treatment seeking behaviours, antibiotic use and relationships to multi-drug resistance

    Open Access•Keina Sado, Katherine Keenan et al.•ARTICLE•PLOS Global Public Health•2024

    Antibacterial resistance (ABR) is a major public health threat. An important accelerating factor is treatment-seeking behaviour, including inappropriate antibiotic (AB) use. In many low- and middle-income countries (LMICs) this includes taking ABs with and without prescription sourced from various providers, including health facilities and community drug sellers. However, investigations of complex treatment-seeking, AB use and drug resistance in …

  • Wastewater metagenomics in Africa

    Open Access•Stephen Kanyerezi, Fatma Z Guerfali et al.•ARTICLE•PLOS Global Public Health•2024

    The advent of metagenomics has dramatically expanded our understanding of microbial communities, particularly through the study of wastewater, which serves as a rich source of microbial data. In Africa, wastewater metagenomics presents unparalleled opportunities for public health monitoring, antimicrobial resistance (AMR) tracking, and the discovery of new microbial species and functions. Utilizing high-throughput sequencing (HTS) technologies, t…

  • Cross border population movements across three East African states

    Open Access•Patrick King, Mercy Wendy Wanyana et al.•ARTICLE•PLOS Global Public Health•2024

    The frequent population movement across the five East African Countries poses risk of disease spread in the region. A clear understanding of population movement patterns is critical for informing cross-border disease control interventions. We assessed population mobility patterns across the borders of the East African states of Kenya, Uganda, and Rwanda. In November 2022, we conducted Focus Group Discussions (FGDs), Key Informant Interviews (KIIs…

  • Clinical symptoms and faecal shedding of Sars-CoV-2 RNA among hospitalized Covid-19 patients

    Open Access•Rebecca Folasade Bamidele, Adeola Fowotade et al.•ARTICLE•PLOS Global Public Health•2024

    SARS-CoV-2 shedding in human stool has been suggested as a probable route for faeco-oral transmission of the virus due to the availing evidence on the infectivity and pathogenicity of similar highly infectious respiratory viruses. Determining association of SARS-CoV-2 shedding in stools and presenting clinical status might be useful for prediction of the viral transmission spectrum and disease outcome. This study involved a descriptive cross-sect…

  • Treatment seeking and antibiotic use for urinary tract infection symptoms in the time of Covid-19 in Tanzania and Uganda

    Open Access•Emmanuel Olamijuwon, Katherine Keenan et al.•ARTICLE•Journal of Global Health•2024

    Background: There is still little empirical evidence on how the outbreak of coronavirus disease 2019 (COVID-19) and associated regulations may have disrupted care-seeking for non-COVID-19 conditions or affected antibiotic behaviours in low- and middle-income countries (LMICs). We aimed to investigate the differences in treatment-seeking behaviours and antibiotic use for urinary tract infection (UTI)-like symptoms before and during the pandemic at…

  • Adverse Drug Reactions Resulting From the Use of Chiral Medicines Amoxicillin, Amoxicillin-Clavulanic Acid, and Ceftriaxone

    Open Access•Kissa W Mwamwitwa, Elias M Bukundi et al.•ARTICLE•INQUIRY The Journal of Health…•2024

    The use of chiral medicines (possessing center(s) of asymmetric carbon) may cause adverse drug reactions (ADRs). The safety assurance of these medicines is critical. We aimed to evaluate registered and commonly used anti-infective chiral medicines circulating in the Tanzanian market to establish their safety profile to protect public health. A mixed prospective-retrospective cohort study was conducted to assess the safety profile of amoxicillin, …

  • The role of Rwanda Field Epidemiology and Laboratory Training Program graduates and residents in response to the first Marburg Virus Disease outbreak in Rwanda

    Open Access•Edouard Ruseesa, Aphrodis Hagabimana et al.•ARTICLE•PLOS Global Public Health•2025

    Rwanda Field epidemiology and laboratory training programs (RFELTP) build capacity to improve disease surveillance, respond to public health emergencies, and inform evidence-based decision-making to mitigate the impact of epidemics and other public health events. On September 27, 2024, Rwanda declared its first Marburg virus disease (MVD) outbreak. MVD disease is a severe haemorrhagic fever with a fatality rate ranging from 24% to 90%. We describ…

  • Screening and targeted sequencing of stool for microbiologic confirmation and drug resistance determination in paucibacillary tuberculosis

    Open Access•Tara E Ness, Mangaliso Ziyane et al.•ARTICLE•PLOS Global Public Health•2025

    In 2023, an estimated 10.8 million people developed tuberculosis, and 1.25 million people died from this disease, including 161,000 deaths in people with HIV (PWH) in whom tuberculosis remains the leading cause of death. Detecting Mycobacterium tuberculosis drug resistance remains a challenge among patients with paucibacillary tuberculosis; since there is such low bacterial load in their sputum it’s unable to be detected via microscopy, there is …

  • A laboratory-focussed desk review of health systems in Uganda, Kenya, and the UK to respond to current and future pandemics

    Open Access•Winters Muttamba, Bernadette O’hare et al.•ARTICLE•Journal of Global Health•2025

    Background: Laboratory systems play a crucial role in managing diseases effectively, and the COVID-19 pandemic serves as a prime example. The pandemic underscored the need to make laboratory health systems more resilient and robust to respond to future pandemics. Methods: We conducted a desk review guided by the six World Health Organization health system building blocks (health service delivery, health financing, medical products, vaccines, and …

  • Unpacking ‘irrational’ behaviours

    Open Access•Olga Loza, Mike Kesby et al.•ARTICLE•Global Public Health•2025

    Stewardship of antibiotic medicines will likely play a key role in curtailing the rise of antimicrobial resistance (AMR) globally. In East Africa, drug sellers are a critical group for interventions because they often dispense without prescription and violate regulations designed to facilitate antibiotic stewardship. Currently, measures to tackle regulatory avoidance are often rooted in individuated cognitive-behavioural approaches that label sel…

Medicine (11 works) · Disease (6 works) · Environmental health (6 works) · Internal Medicine (5 works) · Pathology (5 works) · Viral Infections and Outbreaks Research (5 works) · Virology (5 works) · Antibiotic Use and Resistance (4 works) · Antibiotics (4 works) · Biology (4 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae